# Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging

> **NCT05045872** · PHASE1 · COMPLETED · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 44 (actual)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **DRUG:** domestic polysaccharide superparamagnetic iron oxide nanoparticle

## Key facts

- **NCT ID:** NCT05045872
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-17
- **Primary completion:** 2024-05-25
- **Final completion:** 2024-09-03
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05045872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05045872, "Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05045872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*